<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02982733</url>
  </required_header>
  <id_info>
    <org_study_id>ATADEK2016/17-4</org_study_id>
    <nct_id>NCT02982733</nct_id>
  </id_info>
  <brief_title>Ankaferd Blood Stopper for Hemostasis After Transradial Coronary Angiography</brief_title>
  <official_title>Ankaferd Blood Stopper as a New Strategy to Avoid Early Complication After Transradial Coronary Angiography: A Randomized, Placebo-Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Acibadem University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Acibadem University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In 2008 Goker et al, introduced Ankaferd Blood Stopper (ABS) as a new hemostatic drug.
      Recently, ABS has been shown to produce local hemostasis by implementing topically after
      major arterial vessel injury. Reducing the compression time during patent hemostasis by
      facilitating hemostasis may decrease RAO. To test this hypothesis the investigators planned a
      three arm randomized study to evaluate the safety and efficacy of Ankaferd blood stopper in
      adjunct to short-time compression, compared to either short-time compression with
      conventional sterile gauzes or with a TR band after transradial diagnostic procedures.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2016</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">November 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Radial artery occlusion assessed by reverse Barbeau's test</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bleeding</measure>
    <time_frame>2 hours</time_frame>
    <description>any kind of bleeding defined as ml after the removal of hemostatic dressings or devices</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hematoma</measure>
    <time_frame>24 hours</time_frame>
    <description>hematomas larger then &gt;5cm</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Radial Artery Injury</condition>
  <condition>Hematoma</condition>
  <condition>Bleed</condition>
  <arm_group>
    <arm_group_label>ABS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ankaferd blood stopper</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CS</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Conventional sterile gauze</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TR BAND</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dedicated hemostatic device</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ABS</intervention_name>
    <description>Ankaferd Blood Stopper</description>
    <arm_group_label>ABS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TR Band</intervention_name>
    <description>Transradial band</description>
    <arm_group_label>TR BAND</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>CS</intervention_name>
    <description>Sterile Gauze</description>
    <arm_group_label>CS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All consecutive patients undergoing transradial elective diagnostic coronary
             procedures between November 2016 and November 2017 at the catheterization laboratory
             of Acibadem University Kocaeli Hospital were considered to be enrolled in the study.

        Exclusion Criteria:

          -  The only exclusion criteria were an abnormal Barbeau's test before puncture and
             failure to provide written informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sevket Gorgulu, Prof</last_name>
    <role>Study Chair</role>
    <affiliation>Acibadem University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sevket Gorgulu, Prof</last_name>
    <phone>02623174121</phone>
    <email>sevket5@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Acibadem University</name>
      <address>
        <city>Ä°stanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sevket Gorgulu, MD</last_name>
      <email>sevket5@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Sevket Gorgulu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 23, 2016</study_first_submitted>
  <study_first_submitted_qc>December 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 5, 2016</study_first_posted>
  <last_update_submitted>December 2, 2016</last_update_submitted>
  <last_update_submitted_qc>December 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 5, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Acibadem University</investigator_affiliation>
    <investigator_full_name>Sevket Gorgulu</investigator_full_name>
    <investigator_title>Prof. Dr.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hematoma</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>October 26, 2017</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

